- €2.62bn
- €2.82bn
- €468.19m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.34 | ||
| PEG Ratio (f) | 0.94 | ||
| EPS Growth (f) | 33.05% | ||
| Dividend Yield (f) | 0.96% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.82 | ||
| Price to Tang. Book | 130.46 | ||
| Price to Free Cashflow | 44.69 | ||
| Price to Sales | 5.28 | ||
| EV to EBITDA | 21.94 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.31% | ||
| Return on Equity | 13.09% | ||
| Operating Margin | 17.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 166.17 | 200.75 | 291.82 | 383.44 | 468.19 | 565.85 | 644.04 | 25.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +3473.7 | +104.92 | +84.82 | +16.16 | +35.57 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Exosens SA is a France-based company that develops, manufactures, and markets amplification, detection, and imaging technologies for the defense and surveillance, life sciences and environment, industrial control, and nuclear sectors. The Company offers electro-optical products and systems, including imaging cameras, infrared and hyperspectral imaging systems, image intensifier tubes, wavefront sensing and optical metrology instruments, electron, ion, neutron and gamma detectors, ionization chambers, and silicon photodiodes. Its products operate across ultraviolet (UV) to longwave infrared (LWIR) wavelengths and are used in surveillance, scientific research, industrial inspection, environmental monitoring, analytical instrumentation, nuclear safety, and defense applications. The Company conducts research, development, manufacturing, and sales activities and serves customers across Europe, North America, Asia, the Middle East, and other international markets.
Directors
- Jean-Hubert Vial NEC (54)
- Jerome Cerisier CEO (52)
- Christophe Bernardini DRC (63)
- Salim Helou DRC (69)
- Constance Laneque DRC (41)
- Brigitte Geny IND
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- March 16th, 2021
- Public Since
- June 7th, 2024
- No. of Employees
- 1,573
- Sector
- Aerospace & Defense
- Industry
- Industrials
- Exchange
Euronext - Paris- Shares in Issue
- 50,782,552
- Address
- 18 Avenue Pythagore, MERIGNAC, 33700
- Web
- https://www.exosens.com/
- Phone
- +33 555863700
- Contact
- Quynh-Boi Demey
- Auditors
- PricewaterhouseCoopers Audit
Latest News for EXENS
Upcoming Events for EXENS
Full Year 2026 Exosens SA Earnings Release
Similar to EXENS
Airbus SE
Euronext - Paris
Dassault Aviation SA
Euronext - Paris
Drone Volt SA
Euronext - Paris
Exail Technologies SA
Euronext - Paris
Figeac Aero SARL
Euronext - Paris
FAQ
As of Today at 19:34 UTC, shares in Exosens SA are trading at €51.65. This share price information is delayed by 15 minutes.
Shares in Exosens SA last closed at €51.65 and the price had moved by +11.08% over the past 365 days. In terms of relative price strength the Exosens SA share price has underperformed the FTSE Global All Cap Index by -3.28% over the past year.
The overall consensus recommendation for Exosens SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Exosens SA dividend yield is 0.58% based on the trailing twelve month period.
Last year, Exosens SA paid a total dividend of €0.30, and it currently has a trailing dividend yield of 0.58%. We do not have any data on when Exosens SA is to next pay dividends.
We do not have data on when Exosens SA is to next pay dividends. The historic dividend yield on Exosens SA shares is currently 0.58%.
To buy shares in Exosens SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €51.65, shares in Exosens SA had a market capitalisation of €2.62bn.
Here are the trading details for Exosens SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: EXENS
Based on an overall assessment of its quality, value and momentum Exosens SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Exosens SA is €68.50. That is 32.62% above the last closing price of €51.65.
Analysts covering Exosens SA currently have a consensus Earnings Per Share (EPS) forecast of €1.70 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Exosens SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -18.72%.
As of the last closing price of €51.65, shares in Exosens SA were trading -14.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Exosens SA PE ratio based on its reported earnings over the past 12 months is 23.34. The shares last closed at €51.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Exosens SA's management team is headed by:
- Jean-Hubert Vial - NEC
- Jerome Cerisier - CEO
- Christophe Bernardini - DRC
- Salim Helou - DRC
- Constance Laneque - DRC
- Brigitte Geny - IND